Navigation Links
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2012
Date:7/28/2011

Administration clearance and other government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties, risks related to condition of the United States economy and other risks detailed under "Risk Factors" in Abaxis' Annual Report on Form 10-K for the fiscal year ended March 31, 2011 and Abaxis' other periodic reports filed from time to time with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.Financial Tables on Following PagesABAXIS, INC.Condensed Consolidated Statements of Income(In thousands, except per share data)(Unaudited)Three Months EndedJune 30,20112010Revenues

$
36,003

$
34,953Cost of revenues

16,780

15,169Gross profit

19,223

19,784Operating expenses:Research and development

3,454

3,078Sales and marketing

9,152

8,633General and administrative

3,419

2,124Total operating expenses

16,025

13,835Income from operations

3,198

5,949Interest and other income (expense), net

294

(105)Income before income tax provision

3,492

5,844Income tax provision

1,278

2,264Net income

$
2,214

$
3,580Net income per share:  Basic net income per share

$
.10

$
.16  Diluted net income per share

$
.10

$
.16Shares used in the calculation of net income per share:  Weighted average common shares outstanding -
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
2. Abaxis to Present at Jefferies 2011 Global Healthcare Conference
3. Abaxis to Present at ThinkEquitys Second Annual Healthcare Conference
4. Abaxis Receives Presidential "E" Award for Exports
5. Abaxis, Inc. Awarded $650,000 from Kansas Bioscience Authority
6. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
7. Abaxis Appoints Vernon Altman to Board of Directors
8. Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011
9. Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference
10. Abaxis, Inc. to Present at RBC Capital Markets Healthcare Conference
11. Abaxis Reports Financial Performance With Record Sales for the Third Quarter of Fiscal 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
(Date:5/28/2015)... VANCOUVER and HOUSTON , May ... "Company") (TSX-V: EPI) today reported financial results for the second ... Amounts, unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded a net ... six months ended March 31, 2015 (Q2-2015), compared to a ...
(Date:5/28/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... H. Mackaness is scheduled to present at the LD ... PT in Los Angeles . ... on the Event Calendar of the Investors section of IRIDEX,s ... will be available shortly after the conclusion of the presentation ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... PITTSBURGH, Feb. 14, 2012  Mylan Inc. (Nasdaq: ... current shortage of preservative-free Methotrexate Injection. Mylan ... of preservative-free Methotrexate Injection in the treatment of patients ... concerns of patients and physicians about access to this ...
... 2012 Masimo (NASDAQ: MASI ) ... Patient Outcomes and Reduce the Cost of Care by Taking ... that continuous noninvasive hemoglobin monitoring (SpHb®) will further the company,s ... B lood T ransfusion R elated ...
Cached Medicine Technology:Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 2Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 3Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 4Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 5Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 6Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 7
(Date:5/29/2015)... IL (PRWEB) May 29, 2015 To ... conducted research, choosing systems that have several awards for ... leaders on what systems stood out to them in ... for inclusion as well. , The 50 Great Health ... , Adventist Health System (Altamonte Springs, Fla.) , Advocate ...
(Date:5/29/2015)... York (PRWEB) May 29, 2015 World ... patented products, announces that it has signed a 10 ... technology patent that aims to let people learn about ... in real time. , "This is an exciting day ... " said Scott J. Cooper, CEO and Creative Director ...
(Date:5/29/2015)... 29, 2015 Mediaplanet has joined forces ... readers on the importance of proper sun protection. The ... Today, with a circulation of approximately 250,000 copies and ... is distributed nationally, through a vast social media strategy, ... partner outlets. To explore the digital version of the ...
(Date:5/29/2015)... May 29, 2015 Shaila Jiwa, a ... Rehab, has recently stated in a new announcement that ... Urinary Continence is commonly seen as a tabooed topic ... help. Expert physiotherapists like Shaila Jiwa try to encourage ... , Incontinence is a condition that can be ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 ... professional and in-depth study on the current state ... the report provides key statistics on the state ... of guidance and direction for companies and individuals ... basic overview of the industry including definitions, classifications, ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2
... to hold the, line on health care cost increases. ... RAPIDS, Mich., Feb. 15 Experts predict,health care costs ... impact of,these increases will have a major effect on ... while others are competing globally,for high tech talent. What ...
... part of new parent company for ... Batesville Casket Company, Stand alone medical technology ... doing business under well-known Hill-Rom brand, ... announced today that it has begun mailing a,notice regarding a special shareholder ...
... masses, study finds , , FRIDAY, Feb. 15 (HealthDay News) ... of two types of hard-to-treat pediatric tumors without harming ... viral therapy, dubbed rQT3, slowed neuroblastoma and peripheral nerve ... the Feb. 15 issue of Cancer Research . ...
... Calif., Feb. 15 Anti-Aging Formulas LLC,( http://www.renuva.net ... and,Mineral Spray, an oral spray with a proprietary ... multivitamin pills., Videos: ... "Unlike tablets, capsules and pills, our Daily ...
... Wis., Feb. 15 Nerites Corporation, a company,that ... medical,devices, today announced it has completed a $5.7 ... of Madison, Wisconsin, with participation by,Black Mountain Ventures ... had raised $3 million from private investors., ...
... specific antigen (PSA) test taken before the age of 50 ... up to 25 years in advance of a diagnosis, according ... Cancer Center in New York and Lund University in Sweden. ... Medicine, should help physicians be able to identify men who ...
Cached Medicine News:Health News:McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 4Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 5Health News:Viral Therapy Slows Pediatric Tumors in Mice 2Health News:New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals 2Health News:Nerites Corporation Announces Closing of Series A Funding Round 2Health News:PSA testing can predict advanced prostate cancer 2
... CV70 cardiovascular ultrasound system provides dedicated ... powerful, all-digital ultrasound system offering exceptional ... sensitivity and spatial resolution everything ... of cardiovascular products. Designed specifically ...
AngioSpeed V series, it is an Angiography system designed for vascular treatment in various radiological regions, cardiology, and neurology. SHIMADZU brings you a single system with all units fused t...
This catheter is intended for ultrasound examination of coronary intravascular pathology only. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Kit for the Preparation of Technetium Tc 99m Teboroxime...
Medicine Products: